Responses
Letters
Refractory adult onset Still’s disease successfully treated with anakinra
Compose a Response to This Article
Other responses
Jump to comment:
- Published on: 9 January 2022
- Published on: 9 January 2022Anakinra in the treatment of refractory adult onset Still’s diseaseShow More
Dear Editor,
We thank Dr Godinho and his co-authors for their report about usefulness of anakinra in the treatment of refractory adult onset Still’s disease (AOSD).
Not all the patients with AOSD have a similar disease course: 4 different disease patterns (monocyclic systemic, monocyclic chronic articular, polycyclic systemic and polycyclic chronic articular) have been described [1]. On the other hand, c...
Conflict of Interest:
None declared.